Eurasian Clinical and Analytical Medicine (Online ISSN: 2667-6451) was founded in 2012 by Derman Medical Publishing. The journal is an international open-access journal containing peer-reviewed high-quality articles in clinical medicine in the areas of all research study types, reviews, and case reports. Our journal has become an important platform with the help of language support services, which make it easier for writers who have English as their second language to share their clinical experiences with the world. Our Journal is dedicated to the dissemination of the unique papers to all researchers, scientists, and clinicians to promote and share progress within the scope of the journal. The journal is published three times in a year and inJanuary, May and September. Articles in English are accepted. The authors undertake all scientific responsibility for their manuscripts. All the printed and digital content of this journal is archived in the ULAKBİM National Databases, Pleksus Medline and Türkiye Atıf Dizini.
Statement of informed approval about the study from every participant must obtained. In such studies, the authors must specify that they comply with the international guidelines, the “Regulations on Pharmaceutical Research” enforced by The Ministry of Health of Turkey published in the 27089 numbered Official Journal dated 23 December 2008, and the other regulations published later and all procedures performed in studies involving human participants should be in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. It should be expressed that in the experimental studies that all animals are subject to the ethical treatment in accordance with Guide for the Care and Use of Laboratory Animals. Editors expect that all investigations involving humans are performed in accordance with these principles. For animal experimentation reported in the journal, it is expected that investigators observe the Interdisciplinary Principles and Guidelines for the Use of Animals in Research, Testing, and Education issued by the New York Academy of Sciences' Adhoc Committee on Animal Research. Studies on animals require ethical approval.
When the submitted articles arrived to the journal, one of the Editors read each manuscript. Editors have to decided first decision very quickly. We aim to reach a first decision on all manuscripts within one or two weeks of submission. During the first decision, journal editors mainly check: does the manuscript fit the journals scope and aim and minimum acceptable quality? Is the manuscript compliant with the journals instructions for author? Editor decides whether or not to send it for full peer review. If a paper is rejected without external review, authors are notified electronically on decision time by email. We retain copies of rejected manuscripts for three months, after which we delete them from our system. Only after clearing the initial screening is the manuscript sent to double blind peer reviewers. Minimum of two peer reviewers are selected for peer-review process. Names of reviewers and authors are not revealed to each other. We ask authors to declare potential conflicts of interest any of the reviewers. The final decision concerning the manuscript is made during the regular Editorial meeting. All the evaluation reports from the reviewers are reviewed and final decision is reached on the base of originality, quality, importance, scientific merit and ethical issues of the article. All authors are asked to submit any conflict of interest and complete and sign the Copyright Release Form. We send the reviewers’ comments to authors whether or not we accept the article. Linguistic corrections are made by the native English language editors when we think that it is acceptable. If the manuscript does not seem to fit, it may be better sent straight to another journal.